Targeting CD83 in mantle cell lymphoma with anti-human CD83 antibody.
Ziduo LiEdward AbadirKenneth LeeCandice ClarkeChristian E BryantWendy Anne CooperGeoffrey PieterszJames FavaloroPablo A SilveiraDerek N J HartXinsheng JuGeorgina J ClarkPublished in: Clinical & translational immunology (2020)
This study provides evidence that a novel immunotherapeutic agent CD83 ADC, in combination with chemotherapy, has the potential to enhance the efficacy of current treatments for MCL.